RCT for the Efficacy of Soothing Cream Jel in Improving Upper Limb Pain and Motion

Launched by CHINESE UNIVERSITY OF HONG KONG · Mar 23, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a soothing cream called Jel to see if it helps people with chronic pain in their shoulders or elbows and improves their ability to move these parts of the body. The trial is for adults aged 18 to 60 who regularly exercise and have had this pain for more than three months. To participate, individuals need to have a pain level of 4 or higher on a simple scale and must be willing to sign a consent form.

Participants in the trial will be randomly assigned to receive either the soothing cream or a placebo (a cream that looks the same but has no active ingredients). This means that neither the participants nor the researchers will know who is getting which cream. Throughout the study, participants will complete questionnaires to help assess their pain and movement. It’s important to note that certain individuals, such as those with recent treatments for pain or serious medical conditions, may not be eligible to join. This trial is currently looking for volunteers, and your involvement could help determine if this cream is an effective treatment for upper limb pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18-60;
• • 2. Participates in regular physical activity, at least once a week for 30 minutes;
• • 3. Chronic pain in the shoulder or elbow longer than 3 months;
• • 4. 11-items Numeric pain rating scale ≥4; and
• • 5. Willing to provide written informed consent.
• Exclusion Criteria:
• • 1. The patient had received previous physiotherapy, acupuncture, Tui Na massage, or bone-setting treatment for distal upper limb pain within the past 2 weeks;
• • 2. The pain was due to a fracture or known complex regional pain syndrome.
• • 3. History of upper limb surgery;
• • 4. Known severe medical conditions (e.g. rheumatoid arthritis, osteoporosis, cardiac, renal, hepatic, hematological diseases, vertigo, seizure, infection, malignancy, neurological impairment);
• • 5. Concomitant drugs of NSAIDs, any kind of painkillers, or anti-inflammatory drugs 15 days prior to randomization;
• • 6. Known impaired hematological profile and liver / renal function;
• • 7. Known allergic history to any topical cream;
• • 8. Known pregnant or lactating; or
• • 9. Unable to complete questionnaires